サマリー

COVID-19の大流行により、高流量酸素治療システムの世界市場規模は2021年に5億5433万米ドルと推定され、2028年には4億1162万米ドルに再調整されると予測され、レビュー期間中のCAGRは2.42%となっています。
本レポートでは、世界レベル、地域レベル、企業レベルでの高流量酸素治療システムの数量と価値に焦点を当てています。グローバルな視点から、過去のデータと将来の見通しを分析し、高流動酸素療法システムの全体的な市場規模を表しています。地域的には、このレポートはいくつかの主要地域に焦点を当てています。北米、欧州、中国、日本、その他。

高流動酸素療法システムの世界市場。セグメント別分析
この調査レポートには、地域（国）別、企業別、タイプ別、用途別の具体的なセグメントが含まれています。この調査では、2017年から2028年までの歴史的期間と予測期間における売上高と収益に関する情報を提供しています。セグメントを理解することは、市場の成長を助ける様々な要因の重要性を特定するのに役立ちます。

高流量酸素治療システムの世界市場。セグメント別分析
この調査レポートには、地域（国）別、メーカー別、タイプ別、用途別の具体的なセグメントが含まれています。各タイプは、2017年から2028年の予測期間中の生産に関する情報を提供します。アプリケーション別セグメントはまた、2017年から2028年の予測期間中の消費量を提供します。セグメントを理解することは、市場の成長を助ける様々な要因の重要性を特定するのに役立ちます。

会社別
フィッシャー＆ペイケル・ヘルスケア
TNIメディカル(マシモ)
ミコム・メディカル
RMSメディカル
タレントメディカルエレクトロニクス
ヴェポサーム
テレフレックス
インスパイアード・メディカル（ヴィンセント・メディカル）
アームストロングメディカル
ハミルトンメディカル
グレートグループメディカル
ビヨンドメディカル
BMCメディカル
北京Aeonmed

種類別セグメント
自動酸素濃度調整
手動式酸素濃度調整装置

用途別セグメント
病院用
在宅医療

地域別消費量
北アメリカ
米国
カナダ
アジア太平洋地域
中国
日本
韓国
インド
タイ
インドネシア
フィリピン
バングラデシュ
ネパール
その他の地域
ヨーロッパ
ドイツ
英国
フランス
イタリア
ロシア
ポーランド
スペイン
ルーマニア
カザフスタン
その他の欧州地域
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
ペルー
コロンビア
チリ
ラテンアメリカの残りの地域
中近東・アフリカ
トルコ
サウジアラビア
U.A.E
エジプト
その他の地域

ページTOPに戻る

目次

1 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET OVERVIEW 1
1.1 PRODUCT OVERVIEW AND SCOPE OF HIGH FLOW OXYGEN THERAPY SYSTEMS 1
1.2 HIGH FLOW OXYGEN THERAPY SYSTEMS SEGMENT BY TYPE 1
1.2.1 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES GROWTH RATE COMPARISON BY TYPE (2022-2028) 2
1.2.2 AUTOMATIC OXYGEN ADJUSTMENT 3
1.2.3 MANUAL OXYGEN ADJUSTMENT 4
1.3 HIGH FLOW OXYGEN THERAPY SYSTEMS SEGMENT BY APPLICATION 4
1.3.1 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES COMPARISON BY APPLICATION (2022-2028) 4
1.3.2 HOSPITAL USE 5
1.3.3 HOMECARE 6
1.4 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET SIZE ESTIMATES AND FORECASTS 7
1.4.1 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS REVENUE 2017-2028 7
1.4.2 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES 2017-2028 8
1.4.3 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET SIZE BY REGION: 2017 VERSUS 2021 VERSUS 2028 9
2 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET COMPETITION BY MANUFACTURERS 10
2.1 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES MARKET SHARE BY MANUFACTURERS (2017-2022) 10
2.2 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS REVENUE MARKET SHARE BY MANUFACTURERS (2017-2022) 13
2.3 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS AVERAGE PRICE BY MANUFACTURERS (2017-2022) 15
2.4 MANUFACTURERS HIGH FLOW OXYGEN THERAPY SYSTEMS MANUFACTURING SITES, AREA SERVED, PRODUCT TYPE 16
2.5 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET COMPETITIVE SITUATION AND TRENDS 17
2.5.1 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET CONCENTRATION RATE 17
2.5.2 THE GLOBAL 3 AND 5 LARGEST HIGH FLOW OXYGEN THERAPY SYSTEMS PLAYERS MARKET SHARE BY REVENUE 18
2.5.3 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 19
2.6 MANUFACTURERS MERGERS & ACQUISITIONS, EXPANSION PLANS 20
3 HIGH FLOW OXYGEN THERAPY SYSTEMS RETROSPECTIVE MARKET SCENARIO BY REGION 24
3.1 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS RETROSPECTIVE MARKET SCENARIO IN SALES BY REGION: 2017-2022 24
3.2 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS RETROSPECTIVE MARKET SCENARIO IN REVENUE BY REGION: 2017-2022 24
3.3 NORTH AMERICA HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET FACTS & FIGURES BY COUNTRY 25
3.3.1 NORTH AMERICA HIGH FLOW OXYGEN THERAPY SYSTEMS SALES BY COUNTRY 25
3.3.2 NORTH AMERICA HIGH FLOW OXYGEN THERAPY SYSTEMS REVENUE BY COUNTRY 26
3.3.3 U.S. 27
3.3.4 CANADA 28
3.4 EUROPE HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET FACTS & FIGURES BY COUNTRY 29
3.4.1 EUROPE HIGH FLOW OXYGEN THERAPY SYSTEMS SALES BY COUNTRY 29
3.4.2 EUROPE HIGH FLOW OXYGEN THERAPY SYSTEMS REVENUE BY COUNTRY 30
3.4.3 GERMANY 31
3.4.4 U.K. 32
3.4.5 FRANCE 33
3.4.6 ITALY 34
3.4.7 RUSSIA 35
3.4.8 POLAND 36
3.4.9 SPAIN 37
3.4.10 ROMANIA 38
3.4.11 KAZAKHSTAN 39
3.5 ASIA PACIFIC HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET FACTS & FIGURES BY REGION 40
3.5.1 ASIA PACIFIC HIGH FLOW OXYGEN THERAPY SYSTEMS SALES BY REGION 40
3.5.2 ASIA PACIFIC HIGH FLOW OXYGEN THERAPY SYSTEMS REVENUE BY REGION 41
3.5.3 CHINA 42
3.5.4 JAPAN 43
3.5.5 SOUTH KOREA 44
3.5.6 INDIA 45
3.5.7 THAILAND 46
3.5.8 INDONESIA 47
3.5.9 PHILIPPINES 48
3.5.10 BANGLADESH 49
3.5.11 NEPAL 50
3.6 LATIN AMERICA HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET FACTS & FIGURES BY COUNTRY 51
3.6.1 LATIN AMERICA HIGH FLOW OXYGEN THERAPY SYSTEMS SALES BY COUNTRY 51
3.6.2 LATIN AMERICA HIGH FLOW OXYGEN THERAPY SYSTEMS REVENUE BY COUNTRY 52
3.6.3 MEXICO 53
3.6.4 BRAZIL 54
3.6.5 ARGENTINA 55
3.6.6 PERU 56
3.6.7 COLUMBIA 57
3.6.8 CHILE 58
3.7 MIDDLE EAST AND AFRICA HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET FACTS & FIGURES BY COUNTRY 59
3.7.1 MIDDLE EAST AND AFRICA HIGH FLOW OXYGEN THERAPY SYSTEMS SALES BY COUNTRY 59
3.7.2 MIDDLE EAST AND AFRICA HIGH FLOW OXYGEN THERAPY SYSTEMS REVENUE BY COUNTRY 60
3.7.3 TURKEY 61
3.7.4 SAUDI ARABIA 62
3.7.5 U.A.E 63
3.7.6 EGYPT 64
4 HIGH FLOW OXYGEN THERAPY SYSTEMS HISTORIC MARKET ANALYSIS BY TYPE 65
4.1 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES MARKET SHARE BY TYPE (2017-2022) 65
4.2 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS REVENUE MARKET SHARE BY TYPE (2017-2022) 66
4.3 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS PRICE BY TYPE (2017-2022) 66
5 HIGH FLOW OXYGEN THERAPY SYSTEMS HISTORIC MARKET ANALYSIS BY APPLICATION 67
5.1 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES MARKET SHARE BY APPLICATION (2017-2022) 67
5.2 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS REVENUE MARKET SHARE BY APPLICATION (2017-2022) 67
5.3 GLOBAL HIGH FLOW OXYGEN THERAPY SYSTEMS PRICE BY APPLICATION (2017-2022) 68
6 KEY COMPANIES PROFILED 69
6.1 FISHER & PAYKEL HEALTHCARE 69
6.1.1 FISHER & PAYKEL HEALTHCARE CORPORATION INFORMATION 69
6.1.2 FISHER & PAYKEL HEALTHCARE DESCRIPTION AND BUSINESS OVERVIEW 70
6.1.3 FISHER & PAYKEL HEALTHCARE HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 70
6.1.4 FISHER & PAYKEL HEALTHCARE HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 70
6.1.5 FISHER & PAYKEL HEALTHCARE RECENT DEVELOPMENTS/UPDATES 73
6.2 TNI MEDICAL (MASIMO) 73
6.2.1 TNI MEDICAL (MASIMO) CORPORATION INFORMATION 73
6.2.2 TNI MEDICAL (MASIMO) DESCRIPTION AND BUSINESS OVERVIEW 74
6.2.3 TNI MEDICAL (MASIMO) HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 75
6.2.4 TNI MEDICAL (MASIMO) HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 75
6.2.5 TNI MEDICAL (MASIMO) RECENT DEVELOPMENTS/UPDATES 77
6.3 MICOMME MEDICAL 78
6.3.1 MICOMME MEDICAL CORPORATION INFORMATION 78
6.3.2 MICOMME MEDICAL DESCRIPTION AND BUSINESS OVERVIEW 78
6.3.3 MICOMME MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 79
6.3.4 MICOMME MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 79
6.3.5 MICOMME MEDICAL RECENT DEVELOPMENTS/UPDATES 83
6.4 RMS MEDICAL 84
6.4.1 RMS MEDICAL CORPORATION INFORMATION 84
6.4.2 RMS MEDICAL DESCRIPTION AND BUSINESS OVERVIEW 85
6.4.3 RMS MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 85
6.4.4 RMS MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 86
6.4.5 RMS MEDICAL RECENT DEVELOPMENTS/UPDATES 89
6.5 TALENT MEDICAL ELECTRONICS 90
6.5.1 TALENT MEDICAL ELECTRONICS CORPORATION INFORMATION 90
6.5.2 TALENT MEDICAL ELECTRONICS DESCRIPTION AND BUSINESS OVERVIEW 90
6.5.3 TALENT MEDICAL ELECTRONICS HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 91
6.5.4 TALENT MEDICAL ELECTRONICS HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 91
6.6 VAPOTHERM 92
6.6.1 VAPOTHERM CORPORATION INFORMATION 93
6.6.2 VAPOTHERM DESCRIPTION AND BUSINESS OVERVIEW 93
6.6.3 VAPOTHERM HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 94
6.6.4 VAPOTHERM HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 94
6.6.5 VAPOTHERM RECENT DEVELOPMENTS/UPDATES 96
6.7 TELEFLEX 97
6.7.1 TELEFLEX CORPORATION INFORMATION 97
6.7.2 TELEFLEX DESCRIPTION AND BUSINESS OVERVIEW 97
6.7.3 TELEFLEX HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 98
6.7.4 TELEFLEX HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 98
6.7.5 TELEFLEX RECENT DEVELOPMENTS/UPDATES 100
6.8 INSPIRED MEDICAL (VINCENT MEDICAL) 102
6.8.1 INSPIRED MEDICAL (VINCENT MEDICAL) CORPORATION INFORMATION 102
6.8.2 INSPIRED MEDICAL (VINCENT MEDICAL) DESCRIPTION AND BUSINESS OVERVIEW 102
6.8.3 INSPIRED MEDICAL (VINCENT MEDICAL) HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 103
6.8.4 INSPIRED MEDICAL (VINCENT MEDICAL) HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 103
6.9 ARMSTRONG MEDICAL 104
6.9.1 ARMSTRONG MEDICAL CORPORATION INFORMATION 105
6.9.2 ARMSTRONG MEDICAL DESCRIPTION AND BUSINESS OVERVIEW 105
6.9.3 ARMSTRONG MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 106
6.9.4 ARMSTRONG MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 106
6.9.5 ARMSTRONG MEDICAL RECENT DEVELOPMENTS/UPDATES 108
6.10 HAMILTON MEDICAL 108
6.10.1 HAMILTON MEDICAL CORPORATION INFORMATION 108
6.10.2 HAMILTON MEDICAL DESCRIPTION AND BUSINESS OVERVIEW 109
6.10.3 HAMILTON MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 109
6.10.4 HAMILTON MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 110
6.10.5 HAMILTON MEDICAL RECENT DEVELOPMENTS/UPDATES 114
6.11 GREAT GROUP MEDICAL 114
6.11.1 GREAT GROUP MEDICAL CORPORATION INFORMATION 114
6.11.2 GREAT GROUP MEDICAL DESCRIPTION AND BUSINESS OVERVIEW 115
6.11.3 GREAT GROUP MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 116
6.11.4 GREAT GROUP MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 116
6.12 BEYOND MEDICAL 117
6.12.1 BEYOND MEDICAL CORPORATION INFORMATION 117
6.12.2 BEYOND MEDICAL DESCRIPTION AND BUSINESS OVERVIEW 118
6.12.3 BEYOND MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 119
6.12.4 BEYOND MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 119
6.13 BMC MEDICAL 121
6.13.1 BMC MEDICAL CORPORATION INFORMATION 121
6.13.2 BMC MEDICAL DESCRIPTION AND BUSINESS OVERVIEW 122
6.13.3 BMC MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 123
6.13.4 BMC MEDICAL HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 123
6.14 BEIJING AEONMED 125
6.14.1 BEIJING AEONMED CORPORATION INFORMATION 125
6.14.2 BEIJING AEONMED DESCRIPTION AND BUSINESS OVERVIEW 125
6.14.3 BEIJING AEONMED HIGH FLOW OXYGEN THERAPY SYSTEMS SALES, REVENUE AND GROSS MARGIN (2017-2022) 127
6.14.4 BEIJING AEONMED HIGH FLOW OXYGEN THERAPY SYSTEMS PRODUCT PORTFOLIO 128
6.14.5 BEIJING AEONMED RECENT DEVELOPMENTS/UPDATES 128
7 HIGH FLOW OXYGEN THERAPY SYSTEMS MANUFACTURING COST ANALYSIS 130
7.1 HIGH FLOW OXYGEN THERAPY SYSTEMS KEY RAW MATERIALS ANALYSIS 130
7.1.1 KEY RAW MATERIALS 130
7.1.2 KEY SUPPLIERS OF RAW MATERIALS 130
7.2 PROPORTION OF MANUFACTURING COST STRUCTURE 132
7.3 MANUFACTURING PROCESS ANALYSIS OF HIGH FLOW OXYGEN THERAPY SYSTEMS 133
7.4 HIGH FLOW OXYGEN THERAPY SYSTEMS INDUSTRIAL CHAIN ANALYSIS 134
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS 135
8.1 MARKETING CHANNEL 135
8.2 HIGH FLOW OXYGEN THERAPY SYSTEMS DISTRIBUTORS LIST 136
8.3 HIGH FLOW OXYGEN THERAPY SYSTEMS CUSTOMERS 138
9 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET DYNAMICS 140
9.1 HIGH FLOW OXYGEN THERAPY SYSTEMS INDUSTRY TRENDS 140
9.2 HIGH FLOW OXYGEN THERAPY SYSTEMS GROWTH DRIVERS 140
9.3 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET CHALLENGES 141
9.4 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET RESTRAINTS 141
10 GLOBAL MARKET FORECAST 142
10.1 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET ESTIMATES AND PROJECTIONS BY TYPE 142
10.1.1 GLOBAL FORECASTED SALES OF HIGH FLOW OXYGEN THERAPY SYSTEMS BY TYPE (2023-2028) 142
10.1.2 GLOBAL FORECASTED REVENUE OF HIGH FLOW OXYGEN THERAPY SYSTEMS BY TYPE (2023-2028) 142
10.2 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET ESTIMATES AND PROJECTIONS BY APPLICATION 143
10.2.1 GLOBAL FORECASTED SALES OF HIGH FLOW OXYGEN THERAPY SYSTEMS BY APPLICATION (2023-2028) 143
10.2.2 GLOBAL FORECASTED REVENUE OF HIGH FLOW OXYGEN THERAPY SYSTEMS BY APPLICATION (2023-2028) 144
10.3 HIGH FLOW OXYGEN THERAPY SYSTEMS MARKET ESTIMATES AND PROJECTIONS BY REGION 144
10.3.1 GLOBAL FORECASTED SALES OF HIGH FLOW OXYGEN THERAPY SYSTEMS BY REGION (2023-2028) 144
10.3.2 GLOBAL FORECASTED REVENUE OF HIGH FLOW OXYGEN THERAPY SYSTEMS BY REGION (2023-2028) 145
11 RESEARCH FINDINGS AND CONCLUSION 147
12 METHODOLOGY AND DATA SOURCE 149
12.1 METHODOLOGY/RESEARCH APPROACH 149
12.1.1 RESEARCH PROGRAMS/DESIGN 149
12.1.2 MARKET SIZE ESTIMATION 150
12.1.3 MARKET BREAKDOWN AND DATA TRIANGULATION 151
12.2 DATA SOURCE 152
12.2.1 SECONDARY SOURCES 152
12.2.2 PRIMARY SOURCES 153
12.3 AUTHOR LIST 155
12.4 DISCLAIMER 156